期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^(18)F-FDG PET/CT在恶性淋巴瘤中的临床应用价值 被引量：2

下载PDF
导出
摘要 淋巴瘤是临床上常见的恶性肿瘤之一,起源于淋巴结和淋巴组织,其发生与免疫应答过程中淋巴组织增殖分化产生的某种免疫细胞恶变密切相关。根据细胞形态和组织学特征,分为霍奇金淋巴瘤（Hodgkin’s lymphoma,HD）和非霍奇金淋巴瘤（Hodgkin’Slymphoma，HD）和非霍奇金淋巴瘤（non—Hodgkin’Slymphoma，NHL）两大类。
作者 王朋 兰晓莉 齐红艳 张永学
机构地区 华中科技大学同济医学院附属协和医院核医学科
出处 《华中科技大学学报（医学版）》 CAS CSCD 北大核心 2013年第3期365-368,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家“863计划”资助项目(No.2008AA02Z426)
关键词 淋巴瘤 PET CT 诊断 临床分期 疗效评价 预后评估
分类号 R733.41 [医药卫生—肿瘤]
  • 相关文献

参考文献51

  • 1Harris N L,Jaffe E S,Diebold J,et al. The World Health Or- ganization classification of neoplastic diseases of the haemato- poietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting[M]. Virginia : Airlie House, 1997 : 69-86.
  • 2任金马,蓝绍颖.恶性淋巴瘤的流行病学研究进展[J].南通医学院学报,2003,23(4):523-524. 被引量：19
  • 3贾志云,邓候富,青春.^(18)F-FDGPET或PET/CT显像在淋巴瘤中的应用[J].中国临床医学影像杂志,2008,19(2):125-127. 被引量：17
  • 4Baba S, Abe K, Isoda T, et al. Impact of FDG-PET/CT in the management of lymphoma[J]. Ann Nucl Med, 2011,25 (10) : 701-716.
  • 5Tatsumi M, Cohade C, Nakamoto Y, et al. Direct comparison of FDG PET and CT findings in patients with lymphoma:ini- tial experience[J]. Radiology, 2005,237 (3) : 1038-1045.
  • 6Freudenberg L S, Antoch G, Schutt P, et al. FDG-PET/CT in re-staging of patients with lymphoma[J]. Eur J Nucl Med Mol Imaging,2004,31(3) :325-329.
  • 7Naumann R, Vaic A, Beuthien-Baumann B, et al. Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkins dis- ease and non-Hodgkins lymphoma[J]. Br J Haematol, 2001, 115(4) : 793-800.
  • 8Kasamon Y L, Jones R J,Wahl R L. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma[J]. J Nucl Med,2007,48(Suppl 1):19S-27S.
  • 9Cronin C G, Swords R, Truong M T, et al. Clinical utility of PET/CT in lymphoma[J]. AJR Am J Roentgenol, 2010,194 (1) : W91-W103.
  • 10Seam P,Juweid M E, Cheson B D. The role of FDG-PET scans in patients with lymphoma[J]. Blood, 2007,110 (10): 3507-3516.

二级参考文献88

  • 1管樑 ,Rebecca Elstrom ,Zhuang Hong-ming ,Stephen J.Schuster ,朱承谟 ,Abass Alavi .^(18)F-FDG PET显像对不同亚型淋巴瘤的诊断价值[J].中华核医学杂志,2004,24(4):207-209. 被引量：9
  • 2王辉,江旭峰,王超,李彪,李培勇,朱承谟.^(18)F-FDG PET与^(67)Ga全身显像对淋巴瘤分期的临床价值[J].中华核医学杂志,2005,25(2):100-101. 被引量：7
  • 3Reske SN. PET and restaging of malignant lymphoma including residual masses and relapse. Eur J Nucl Med Mol Imaging, 2003, 30 (Suppl l ) : S89-S96.
  • 4Elstrom R, Guan L, Baker C, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood, 2003,101(10): 3875- 3876.
  • 5Hernandez-Maraver D, Hernandez-Navarro F, Gomez-Leon N et al. Positron emission tomography/computed tomography: diagnostic a accuracy in lymphoma. Br J Haematol, 2006,135(3) :293 -302.
  • 6Menzel C, Dobert N, Mitrou P, et al. Positron emission tomography for the staging of Hodgkin lymphoma increasing the body of evidence in favor of the method. Acta Oncol, 2002,41(5) :430- 436.
  • 7Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol, 2006,17(1) :117-122.
  • 8Allen-Auerbach M, Quon A, Weber WA, et al, Comparison between2 deoxy-2-[18F] fluoro-D-glucose positron emission tomography and Positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol, 2004,6(6) :411-416.
  • 9Schaefer NG, Hany TF, Tavema C, et al, Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging do we need contrast-enhanced CT? Radiology, 2004,232(3) :823-829.
  • 10Buchmann I, Reinhardt M, Eisner K, et al. 2-(fluorine-18) fluo- to-2, deoxy D-glucose positron emission tomography in the detection and staging of malignant lymphoma A bicenter trial. Cancer, 2001,91(5) :889-899.

共引文献43

同被引文献13

引证文献2

二级引证文献14

华中科技大学学报（医学版）
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部